PDGFRA and glioblastoma: Twenty four hours pre-treatment with either PDGFRα blocking antibody (3G3 from Imclone Inc [4]), gB blocking antibody (MAB 758), or the antiviral drug Cidofovir (40μM) inhibited the baseline invasiveness of the primary GBM cells, as shown in Figure 4A (solid bars).